证券代码：603883 证券简称：老百姓 公告编号：2025-029 老百姓大药房连锁股份有限公司 关于 2024 年年度报告的信息披露监管 问询函的回复公告 本公司董事会及全体董事保证本公告内容不存在任何虚假 记载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性 和完整性承担法律责任。 老百姓大药房连锁股份有限公司（以下简称"公司"）收到上海证券交易所 下发的《关于老百姓大药房连锁股份有限公司 2024 年年度报告的信息披露监管 问询函》（上证公函[2025]0625 号）（以下简称"年报问询函"）。公司收到 年报问询函后高度重视，会同安永华明会计师事务所（特殊普通合伙）（以下简 称"年审会计师"）就年报问询函提及的事项逐项进行了认真讨论、核查与落实， 现就有关事项回复如下： 在本问询函相关问题的回复中，若合计数与各分项数值相加之和在尾数上存 在差异，均为四舍五入所致。如无特别说明，本回复中使用的简称或名词释义与 《老百姓大药房连锁股份有限公司 2024 年年度报告》一致。 基于商业秘密和商业敏感信息，根据相关法律法规、规范性文件，对本次问 询函回复中相关内容进行豁免披露处理。 问题 1：关于主营业务与 ...

证券代码：603883 证券简称：老百姓 公告编号：2025-030 会 议 召 开 地 点 ： 上 海 证 券 交 易 所 上 证 路 演 中 心 （ 网 址 ： http://roadshow.sseinfo.com/） 会议召开方式：上证路演中心视频直播和网络互动 投资者可于 2025 年 6 月 23 日(星期一)至 6 月 27 日(星期五)16:00 前登录上 证路演中心网站首页点击"提问预征集"栏目或通过公司邮箱 ir@lbxdrugs.com 进行提问。公司将在说明会上对投资者普遍关注的问题进行回答。 老百姓大药房连锁股份有限公司 关于召开 2024 年度暨 2025 年第一季度业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记 载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和 完整性承担法律责任。 重要内容提示： 会议召开时间：2025 年 6 月 30 日(星期一)上午 10:00-11:30 本次投资者说明会以视频结合网络互动召开，公司将针对 2024 年及 2025 年第一季度经营成果及财务指标的具体情况与投资者进行互动交流和沟通，在信 息披露允许的范围内就 ...

2024 年年度股东大会会议资料 老百姓大药房连锁股份有限公司 2024 年年度股东大会会议资料 股票代码：603883 二〇二五年六月 1 / 32 2024 年年度股东大会会议资料 目 录 1、关于公司 2024 年度报告及摘要的议案 2、关于公司 2024 年度董事会工作报告的议案 3、关于公司 2024 年度监事会工作报告的议案 4、关于 2024 年度利润分配预案的议案 5、关于提请股东大会授权董事会制定中期分红方案的议案 6、关于公司续聘会计师事务所的议案 7、关于公司及子公司 2025 年度申请银行综合授信额度及提供 担保的议案 8、关于公司 2024 年度董事、监事、高级管理人员报酬总额的 议案 9、关于 2025-2026 年度日常关联交易预计的议案 2 / 32 一、会议须知 二、会议议程 三、会议议案 2024 年年度股东大会会议资料 四、本次大会谢绝股东及股东代理人个人录音、拍照及录像，对扰乱会议的 正常秩序和会议议程、侵犯公司和其他股东及股东代理人的合法权益的行为，会 议工作人员有权予以制止，并及时报有关部门处理。 五、出席大会的股东依法享有发言权、质询权、表决权等股东权利。参会股 ...

Core Insights - The event "2025 Asset Management and Wealth Management Industry Development Conference and the 5th 'Golden Honor Award' Ceremony" was held in Chengdu, where Ping An Wealth Management received multiple awards for its investment research capabilities and technological advancements [1] Group 1: Company Achievements - Ping An Wealth Management was awarded "Outstanding Wealth Management Company" and "Outstanding Technological Strength Institution" at the conference [1] - The company's product "Qiyuan Strategy (360 Days Holding) No. 1" was recognized as an "Excellent Fixed Income Bank Wealth Management Product" [1][4] - The product has achieved a net value growth rate of 10.40% since its inception, with an annualized return of 3.92% and a maximum drawdown of only -0.32% [4] Group 2: Strategic Focus - Ping An Wealth Management aims to create the "most comprehensive open wealth management platform in China," enhancing its capabilities in investment research, product systems, channel management, operational services, and risk management [3] - The company is focusing on a dual-engine strategy of diversified talent and data technology innovation to build a competitive advantage [3] Group 3: Technological Innovations - The company has made significant advancements in technology, establishing an AI-driven marketing system that integrates large and small model architectures for comprehensive data governance [3] - The AI framework allows for flexible task execution and cross-domain collaboration, enhancing efficiency and accuracy in investment decision-making [3] Group 4: Market Position - Ping An Wealth Management ranks second in the "2024 Half-Year Comprehensive Competitiveness Ranking of Bank Wealth Management Companies" published by Peking University [5] - The company also ranks second in terms of yield capability and information disclosure friendliness, and fifth in operational management capability in the national wealth management capability ranking [5] Group 5: Product Offerings - The company has developed a multi-asset and multi-strategy product matrix called "Quanxin Quanyi," focusing on various strategies to provide a stable investment experience [6] - Recent statistics show that the annualized returns for pure fixed income products over the past two and three years are above 2.79% and 3.32%, respectively [6]

Investment Rating - The report maintains a "Buy" rating for the company, with a previous rating also being "Buy" [1][5]. Core Views - The company reported a revenue of RMB 22.358 billion for 2024, a slight decrease of 0.36% year-on-year, and a net profit of RMB 5.19 billion, down 44.13% year-on-year. The first quarter of 2025 saw a revenue of RMB 54.35 billion, a decrease of 1.88% year-on-year, with a net profit of RMB 2.51 billion, down 21.98% year-on-year. Despite short-term profit pressures, the company is expected to improve profitability through its franchise business and Torch project [3][5][8]. Summary by Sections Financial Performance - In 2024, the company achieved a total revenue of RMB 22.358 billion, with a net profit of RMB 5.19 billion, reflecting a year-on-year decrease of 44.13%. The first quarter of 2025 showed a revenue of RMB 54.35 billion and a net profit of RMB 2.51 billion, both lower than the previous year [3][8]. Profitability Forecast - The adjusted net profit forecasts for 2025-2027 are RMB 6.91 billion, RMB 10.00 billion, and RMB 11.47 billion respectively, with corresponding EPS of RMB 0.91, RMB 1.32, and RMB 1.51. The valuation multiples based on the closing price as of June 11, 2025, are 22.9x, 15.8x, and 13.8x for the respective years [5][7]. Business Expansion - The company has expanded its store network to 15,252 locations, including 9,844 direct-operated stores and 5,408 franchise stores. The franchise business is growing rapidly, with a 62% share of old store franchises, up 34 percentage points year-on-year. The franchise business generated over RMB 5.8 billion in distribution revenue in Q1 2025 [8][9]. Strategic Initiatives - The Torch project is aimed at enhancing profitability and exploring new growth avenues. In Q1 2025, the company achieved a gross margin of 34.22%, with offline sales gross margin increasing by 0.70 percentage points year-on-year. The company is also diversifying its projects to increase the non-pharmaceutical sales ratio [8][9].

Core Viewpoint - The article highlights the life and contributions of Du Shilin, a centenarian veteran who participated in the anti-Japanese resistance during World War II, emphasizing his dedication to both military service and agricultural work in his later years [7][12]. Group 1: Early Life and Military Involvement - Du Shilin joined the anti-Japanese children's group at the age of 11, motivated by the desire for food and influenced by his uncle, who was a guerrilla leader [8]. - He undertook various roles, including gathering intelligence for the guerrilla forces, and demonstrated bravery by enduring torture without revealing military secrets when captured by the Japanese [9]. Group 2: Community Support and Military Discipline - The article discusses the strong bond between the Eight Route Army and local civilians, highlighting how the army's strict discipline earned the trust and support of the people [10]. - Du Shilin recalls instances where local residents provided food and assistance to soldiers, showcasing the mutual respect and cooperation during the war [10]. Group 3: Post-War Life and Legacy - After the war, Du Shilin returned to farming and continued to share his experiences with younger generations, emphasizing the importance of hard work and appreciation for the peace achieved through sacrifice [12][14]. - His recent trip to Beijing fulfilled a long-held wish to honor his fallen comrades, reflecting his enduring commitment to the values of service and remembrance [12].

证券代码：603883 证券简称：老百姓 公告编号：2025-028 老百姓大药房连锁股份有限公司 关于召开2024年年度股东大会的通知 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 股东大会召开日期：2025年6月30日 本次股东大会采用的网络投票系统：上海证券交易所股东大会网络投票 系统 一、 召开会议的基本情况 (一)股东大会类型和届次 2024年年度股东大会 (二)股东大会召集人：董事会 (三)投票方式：本次股东大会所采用的表决方式是现场投票和网络投票相结合的 方式 (四)现场会议召开的日期、时间和地点 召开的日期时间：2025 年 6 月 30 日15 点 30 分 召开地点：湖南省长沙市开福区青竹湖路 808 号老百姓 15 楼会议室 (五)网络投票的系统、起止日期和投票时间 网络投票系统：上海证券交易所股东大会网络投票系统 网络投票起止时间：自2025 年 6 月 30 日至2025 年 6 月 30 日 采用上海证券交易所网络投票系统，通过交易系统投票平台的投票时间为股 东大会召开当日的交易时 ...

Core Viewpoint - The newly introduced "Regulations on Government Data Sharing" aims to enhance the efficiency and effectiveness of government services through secure and orderly sharing of government data, ultimately contributing to the construction of a digital government [1] Group 1: Importance of Data Sharing - Government data sharing is essential to eliminate "data silos" that hinder inter-departmental collaboration and reduce administrative efficiency, thereby improving the experience for businesses and citizens [2] - By integrating and analyzing multi-dimensional data, government decision-making can become more scientific and efficient, leading to better management outcomes [4] Group 2: Implementation of Data Sharing - The regulations categorize government data into three types: unconditional sharing, conditional sharing, and non-sharing, ensuring that data sharing is not obstructed by arbitrary conditions [7] - The application process for data sharing is clearly defined, with specific timelines for responses and sharing, which facilitates faster data flow between departments [9] Group 3: Overcoming Barriers and Enhancing Value - The introduction of these regulations aims to break down existing barriers to data sharing, thereby unlocking the potential value of government data for various sectors, including economic development and social governance [12] - Citizens will benefit from reduced administrative burdens, as data sharing will minimize the need for repeated submissions of documents and forms, enhancing the overall experience when interacting with government services [14]

Core Viewpoint - The announcement details the share pledge situation of the controlling shareholder, Lao Bai Xi Medicine Group, which holds 26.12% of the total shares of Lao Bai Xi Pharmacy Chain Co., Ltd. and has pledged 137,950,000 shares, accounting for 18.15% of the total share capital [1] Summary by Sections Share Pledge of Listed Company - The controlling shareholder, Lao Bai Xi Medicine Group, has pledged part of its shares, with the pledgee being Bank of China International Securities Co., Ltd. The pledged shares amount to 1,235,000 shares, with a pledge start date of June 5, 2025, and an expiration date of June 4, 2026 [1] Cumulative Pledge Situation of Controlling Shareholder and Concerted Actors - As of the announcement date, the cumulative pledge situation of the controlling shareholder and concerted actors is as follows: Lao Bai Xi Medicine Group holds 198,564,175 shares (26.12%), with 137,950,000 shares pledged (69.47% of its holdings, 18.15% of total shares) [2][5] Pledge Risk Management - The company indicates that the pledge risk is controllable, with future repayment sources primarily from dividends, investment income, and self-raised funds. In case of margin call risks, the group will take measures such as additional pledges or early repayments [5]

老百姓大药房连锁股份有限公司 1、本次股份质押基本情况 证券代码：603883 证券简称：老百姓 公告编号：2025-027 关于控股股东股票质押的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承 担法律责任。 重要内容提示： ●老百姓大药房连锁股份有限公司（以下简称"公司"）控股股东老百姓医药集 团有限公司（以下简称"医药集团"）持有公司股份数量为 198,564,175 股，占公司 总股本比例为 26.12%；累计质押股份数量为 137,950,000 股（含本次质押），占其所 持股份比例为 69.47%，占公司总股本比例为 18.15%。控股股东及一致行动人（医药集 团与陈秀兰）合计持有公司股份数量为 212,129,873 股，占公司总股本比例为 27.91%； 累计质押股份数量为 137,950,000 股（含本次质押），占其所持股份比例为 65.03%， 占公司总股本比例为 18.15%。 一、上市公司股份质押 公司于 2025 年 6 月 5 日获悉控股股东医药集团所持有的部分公司股份被质押，质 权人为中银国际证券股份有 ...